FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to novel substituted derivatives of urea, which possess properties of selective modulator of cardiac sarcomere, for instance, enhance action of cardiac myosin. Novel compounds are selected from compounds corresponding to structural formulas: .
EFFECT: compounds can be used in treatment for heart failure, in particular in treatment of systolic heart failure and congestive heart failure.
30 cl, 17 ex
Title | Year | Author | Number |
---|---|---|---|
PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
PYRIDINE DERIVATIVES CONDENSED WITH HETEROCYCLE | 1996 |
|
RU2136683C1 |
BICYCLIC PYRIDINES AND ANALOGUES AS SIRTUIN MODULATORS | 2010 |
|
RU2550821C2 |
COMPOUNDS WITH NEMATICIDAL ACTIVITY | 2012 |
|
RU2608217C2 |
COMPOUNDS | 2018 |
|
RU2774952C2 |
CERTAIN CHEMICAL COMPOUNDS, COMPOSITIONS AND METHODS | 2014 |
|
RU2718876C2 |
NOVEL COMPOUNDS AND FASN INHIBITION COMPOSITIONS | 2014 |
|
RU2737434C2 |
PYRIDINAMINPYRIDONES AND PYRIMIDINAMINPYRIDONES | 2018 |
|
RU2804638C2 |
RING-CONDENSED COMPOUNDS AND THEIR USING AS MEDICINAL AGENTS | 2000 |
|
RU2223761C2 |
DERIVATIVES OF INDOLIN-2-SHE AS INHIBITORS OF PROTEINKINAS | 2013 |
|
RU2627706C2 |
Authors
Dates
2011-01-27—Published
2005-06-16—Filed